Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

RecruitingOBSERVATIONAL
Enrollment

163

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Triple Negative Breast CancerOrganoid
Interventions
OTHER

Establishment of ex vivo breast cancer organoid models

This study includes 2 steps: The constitution of a collection of tumor and blood samples and the analysis of the ex vivo response of the tumor samples to the treatments for the development of functional tests and the research of predictive biomarkers of this response

Trial Locations (1)

14076

RECRUITING

Centre François Baclesse, Caen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER